Dale Bratzler, DO, MPH

Dale W. Bratzler, DO, MPH, is the Dean of the Hudson College of Public Health. He has served as a Professor and Chair of the Department of Health Administration and Policy at the Hudson College of Public Health and is a Professor in the Department of Internal Medicine in the College of Medicine at the University of Oklahoma (OU) Health Sciences Center. Dr. Bratzler is the Chief COVID Officer for the University of Oklahoma and the Chief Quality Officer for the three-hospital health system and faculty practice at OU Health.  He has served two terms as president of the American Health Quality Association and was appointed to the National Advisory Council for the Agency for Healthcare Research and Quality from 2005 to 2008 by then HHS Secretary Mike Leavitt. He has served on or chaired multiple standing consensus committees for the National Quality Forum.

For more than 20 years, Dr. Bratzler has participated in research on prevention of surgical infections and on adult vaccination. He was appointed to the CDC’s Healthcare Infection Control Practices Advisory Committee by then HHS Secretary Kathleen Sebelius and subsequently spent a year as a Senior Policy Advisor for the CDC.  He has served on or chaired multiple standing committees for the National Quality Forum. He has given more than 600 lectures nationally on health care quality topics with a particular emphasis on prevention of surgical site infections and adult vaccination and has published more than 100 manuscripts in journals such as the New England Journal of Medicine, Journals of the American Medical Association, Health Affairs and others.  Board certified in internal medicine, he is a Master Fellow of the American College of Osteopathic Internists, and a Fellow of the Infectious Diseases Society of America.

Preventing Mortality and Morbidity through Evidence-Based Antiviral
Treatment of Non-hospitalized Adults with COVID-19

Objectives:

  • Acquire knowledge and confidence in evidence-based care delivery for patients at risk for severe COVID-19.
  • Discuss with patients how treatment relates to other best practices, such as prevention measures.